Lomond Therapeutics Files 8-K
| Field | Detail |
|---|---|
| Company | Lomond Therapeutics Holdings, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-disclosure, corporate-update
TL;DR
Lomond Therapeutics filed an 8-K on 6/20/25 for Reg FD and financials.
AI Summary
Lomond Therapeutics Holdings, Inc. filed an 8-K on June 20, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Venetian-1 Acquisition Corp., is incorporated in Delaware and its principal executive offices are located in Dover, DE.
Why It Matters
This filing indicates that Lomond Therapeutics Holdings, Inc. is providing updated information and financial disclosures to the SEC, which is standard for public companies.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K for financial statements and disclosures, not indicating any specific adverse events.
Key Numbers
- 000-56377 — Commission File Number (Identifier for the company's SEC filings)
- 87-2959575 — IRS Employer Identification No. (Tax identification number for the company)
Key Players & Entities
- Lomond Therapeutics Holdings, Inc. (company) — Registrant
- Venetian-1 Acquisition Corp. (company) — Former company name
- June 20, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Dover, Delaware (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose is to report a Regulation FD Disclosure and to file Financial Statements and Exhibits as of June 20, 2025.
When was the earliest event reported in this filing?
The earliest event reported is dated June 20, 2025.
What was Lomond Therapeutics Holdings, Inc. formerly known as?
Lomond Therapeutics Holdings, Inc. was formerly known as Venetian-1 Acquisition Corp.
In which state is Lomond Therapeutics Holdings, Inc. incorporated?
The company is incorporated in Delaware.
What is the address of the principal executive offices?
The principal executive offices are located at 8 The Green Ste 8490, Dover, Delaware, 19901.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding Lomond Therapeutics Holdings, Inc..